Contineum Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding for Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Contineum Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate for Q2 2024.
  • Contineum Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 13, 2024 was 19M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 19M Aug 13, 2024 10-Q 2024-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.